{"schema_version":"secwatch.filing_event.v1","accession":"0001110803-26-000018","form_type":"8-K","ticker":"ILMN","cik":"0001110803","company_name":"ILLUMINA, INC.","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.552851+00:00","generated_at":"2026-05-16T04:17:01.556408+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Illumina Q4 revenue $1.16B (+5%), GAAP EPS $2.16; guides FY2026 rev $4.5-$4.6B","bullets":["Revenue $1.16B in Q4 2025, up 5% YoY; ex-China revenue up 8%.","GAAP diluted EPS $2.16; non-GAAP diluted EPS $1.35.","FY2025 revenue $4.34B flat YoY; GAAP EPS $5.45, non-GAAP EPS $4.84.","FY2026 guidance: revenue $4.5-$4.6B (4-6% growth); non-GAAP EPS $5.05-$5.20.","Completed SomaLogic acquisition; China MOFCOM export ban lifted; launched Billion Cell Atlas with partners."],"urls":{"canonical":"https://secwatch.observer/filing/0001110803-26-000018","json":"https://secwatch.observer/filing/0001110803-26-000018.json","markdown":"https://secwatch.observer/filing/0001110803-26-000018.md","text":"https://secwatch.observer/filing/0001110803-26-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000018/0001110803-26-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000018/ilmn-20260205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:17:01.556408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}